Clinical trials: High-Risk Stroke Population
Hypertension, Mhealth
Effect of Digital Intervention on Self-management of Hypertensive Patients at High Risk of Stroke
Stroke is the second leading cause of death in the world, and the number of stroke patients in China ranks the first in the world. Hypertension is the most important risk factor.
- Trial name
- NCT07089810
- Testing
- Digital intervention has a high blood pressure in the high-risk population of stroke Study on the effect of stress on self-management behavior of patients
- Volunteers
- 120 people
- Sponsor
- Affiliated Hospital of Nantong University
Cognitive Impairment, Dementia
Smartphone Multimodal Health Intervention for Neurological Enhancement (SHINE)
This randomized controlled trial will enroll individuals aged ≥ 40 years without dementia who are at high risk for stroke, collecting multi-modal MRI imaging, serum, and fecal samples to investigate the effects of a…
- Conditions
- Cognitive Impairment, Dementia, Artificial Intelligence (AI), Stroke
- Trial name
- NCT07092371
- Testing
- Digital Multimodal Intervention
- Where
- China
- Volunteers
- 1,036 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Diabetes, Hypertension
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge.
- Conditions
- Diabetes, Hypertension, High Cholesterol/Hyperlipidemia, Coronary Artery Disease
- Trial name
- MedAAAction (NCT06374277)
- Testing
- Med AAAction intervention
- Where
- 2 sites in United States
- Volunteers
- 388 people
- Sponsor
- University of Tennessee